Human metabolic phenotyping and metabolome wide association studies.

[1]  Ian J. Brown,et al.  Human metabolic phenotype diversity and its association with diet and blood pressure , 2008, Nature.

[2]  E. Holmes,et al.  Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. , 2008, Environmental microbiology.

[3]  Kirill Veselkov,et al.  Species variation in the fecal metabolome gives insight into differential gastrointestinal function. , 2008, Journal of proteome research.

[4]  Elaine Holmes,et al.  Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach. , 2007, Journal of proteome research.

[5]  Elaine Holmes,et al.  Topographical variation in metabolic signatures of human gastrointestinal biopsies revealed by high-resolution magic-angle spinning 1H NMR spectroscopy. , 2007, Journal of proteome research.

[6]  Kenji Kanazawa,et al.  NMR metabolic profiling combined with two-step principal component analysis for toxin-induced diabetes model rat using urine. , 2007, The Journal of toxicological sciences.

[7]  Russ Greiner,et al.  Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. , 2007, Analytical chemistry.

[8]  Ralf J. O. Torgrip,et al.  Proof of principle of a generalized fuzzy Hough transform approach to peak alignment of one-dimensional 1H NMR data , 2007, Analytical and bioanalytical chemistry.

[9]  Pedro R Cutillas,et al.  Combined proteomic and metabonomic studies in three genetic forms of the renal Fanconi syndrome. , 2007, American journal of physiology. Renal physiology.

[10]  J. Nicholson,et al.  Experimental and analytical variation in human urine in 1H NMR spectroscopy-based metabolic phenotyping studies. , 2007, Analytical chemistry.

[11]  Elaine Holmes,et al.  Metabonomic studies on the physiological effects of acute and chronic psychological stress in Sprague-Dawley rats. , 2007, Journal of proteome research.

[12]  Dominique Gauguier,et al.  Direct quantitative trait locus mapping of mammalian metabolic phenotypes in diabetic and normoglycemic rat models , 2007, Nature Genetics.

[13]  Aki Vehtari,et al.  A novel Bayesian approach to quantify clinical variables and to determine their spectroscopic counterparts in 1H NMR metabonomic data , 2007, BMC Bioinformatics.

[14]  Jeremiah Stamler,et al.  Detection of urinary drug metabolite (xenometabolome) signatures in molecular epidemiology studies via statistical total correlation (NMR) spectroscopy. , 2007, Analytical chemistry.

[15]  I. Wilson,et al.  Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. , 2007, Journal of proteome research.

[16]  Chen Yang,et al.  Comparative Metabolomics of Breast Cancer , 2006, Pacific Symposium on Biocomputing.

[17]  Yulan Wang,et al.  Chapter 11 – Exploiting the Potential of Metabonomics in Large Population Studies: Three Venues , 2007 .

[18]  John C. Lindon,et al.  The handbook of metabonomics and metabolomics , 2007 .

[19]  Yi-Zeng Liang,et al.  Plasma fatty acid metabolic profiling and biomarkers of type 2 diabetes mellitus based on GC/MS and PLS‐LDA , 2006, FEBS letters.

[20]  M. Agostini,et al.  Multivariate analysis approach to the plasma protein profile of patients with advanced colorectal cancer. , 2006, Journal of mass spectrometry : JMS.

[21]  Oliver Fiehn,et al.  Pathway analysis of kidney cancer using proteomics and metabolic profiling , 2006, Molecular Cancer.

[22]  O. Fiehn,et al.  Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. , 2006, Cancer research.

[23]  Kieran Clarke,et al.  A combined 1H-NMR spectroscopy- and mass spectrometry-based metabolomic study of the PPAR-alpha null mutant mouse defines profound systemic changes in metabolism linked to the metabolic syndrome. , 2006, Physiological genomics.

[24]  Burton H Singer,et al.  Combinations of biomarkers predictive of later life mortality , 2006, Proceedings of the National Academy of Sciences.

[25]  M. Rantalainen,et al.  Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice. , 2006, Journal of proteome research.

[26]  M. McCarthy,et al.  Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice , 2006, Proceedings of the National Academy of Sciences.

[27]  Elaine Holmes,et al.  Impact of analytical bias in metabonomic studies of human blood serum and plasma. , 2006, Analytical chemistry.

[28]  H. Senn,et al.  Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. , 2006, Analytical chemistry.

[29]  Julian L Griffin,et al.  Proton NMR analysis of plasma is a weak predictor of coronary artery disease , 2006, Nature Medicine.

[30]  Johan Lindberg,et al.  Predictive metabolite profiling applying hierarchical multivariate curve resolution to GC-MS data--a potential tool for multi-parametric diagnosis. , 2006, Journal of proteome research.

[31]  J. Lindon,et al.  Pharmaco-metabonomic phenotyping and personalized drug treatment , 2006, Nature.

[32]  David Broadhurst,et al.  Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles. , 2006, Brain : a journal of neurology.

[33]  Elaine Holmes,et al.  Metabolic profiling of plasma from discordant schizophrenia twins: correlation between lipid signals and global functioning in female schizophrenia patients. , 2006, Journal of proteome research.

[34]  P. Elliott,et al.  Assessment of analytical reproducibility of 1H NMR spectroscopy based metabonomics for large-scale epidemiological research: the INTERMAP Study. , 2006, Analytical chemistry.

[35]  M. Rantalainen,et al.  The comparative metabonomics of age-related changes in the urinary composition of male Wistar-derived and Zucker (fa/fa) obese rats. , 2006, Molecular bioSystems.

[36]  Elaine Holmes,et al.  Metabolic characterization of the R6/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopy. , 2006, Journal of proteome research.

[37]  Robert S Plumb,et al.  Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: application in metabonomic toxicology studies. , 2006, Analytical chemistry.

[38]  Frederick P Roth,et al.  Metabolomic Identification of Novel Biomarkers of Myocardial Ischemia , 2005, Circulation.

[39]  Muireann Coen,et al.  Proton nuclear magnetic resonance-based metabonomics for rapid diagnosis of meningitis and ventriculitis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  I. Wilson,et al.  A combined (1)H NMR and HPLC-MS-based metabonomic study of urine from obese (fa/fa) Zucker and normal Wistar-derived rats. , 2005, Journal of pharmaceutical and biomedical analysis.

[41]  Jennifer H Granger,et al.  A rapid screening approach to metabonomics using UPLC and oa-TOF mass spectrometry: application to age, gender and diurnal variation in normal/Zucker obese rats and black, white and nude mice. , 2005, The Analyst.

[42]  J. Griffin,et al.  Metabolic characterization of distinct neuroanatomical regions in rats by magic angle spinning 1H nuclear magnetic resonance spectroscopy , 2005, Magnetic resonance in medicine.

[43]  Stephen J. Bruce,et al.  Extraction, interpretation and validation of information for comparing samples in metabolic LC/MS data sets. , 2005, The Analyst.

[44]  Alan Hutson,et al.  Detection of epithelial ovarian cancer using 1H‐NMR‐based metabonomics , 2005, International journal of cancer.

[45]  D. Gauguier,et al.  Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets. , 2005, Analytical chemistry.

[46]  John C Lindon,et al.  Sample classification based on Bayesian spectral decomposition of metabonomic NMR data sets. , 2004, Analytical chemistry.

[47]  J. Nicholson,et al.  Metabolomic strategy for the classification and quality control of phytomedicine: a case study of chamomile flower (Matricaria recutita L.). , 2004, Planta medica.

[48]  Jeremiah Stamler,et al.  Ethyl glucoside in human urine following dietary exposure: detection by 1H NMR spectroscopy as a result of metabonomic screening of humans. , 2004, The Analyst.

[49]  D. Leibfritz,et al.  High-resolution 1H NMR spectroscopy of cerebrospinal fluid in spinal diseases , 2004, Neurosurgical Review.

[50]  J. Haselden,et al.  Use of liquid chromatography/time-of-flight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids. , 2003, Rapid communications in mass spectrometry : RCM.

[51]  Anthony F. P. Nash,et al.  A 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects. , 2003, Journal of pharmaceutical and biomedical analysis.

[52]  H Kesteloot,et al.  INTERMAP: background, aims, design, methods, and descriptive statistics (nondietary) , 2003, Journal of Human Hypertension.

[53]  Jan van der Greef,et al.  Identification of disease- and nutrient-related metabolic fingerprints in osteoarthritic Guinea pigs. , 2003, The Journal of nutrition.

[54]  J. Nicholson,et al.  Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics , 2002, Nature Medicine.

[55]  B. McEwen,et al.  Sex, stress and the hippocampus: allostasis, allostatic load and the aging process , 2002, Neurobiology of Aging.

[56]  J. Nicholson,et al.  Multi-component metabolic classification of commercial feverfew preparations via high-field 1H-NMR spectroscopy and chemometrics. , 2002, Planta medica.

[57]  J. Lindon,et al.  Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.

[58]  E Holmes,et al.  Investigations into biochemical changes due to diurnal variation and estrus cycle in female rats using high-resolution (1)H NMR spectroscopy of urine and pattern recognition. , 2001, Analytical biochemistry.

[59]  D. DeMets,et al.  Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.

[60]  I. Wilson,et al.  An NMR‐based metabonomic approach to investigate the biochemical consequences of genetic strain differences: application to the C57BL10J and Alpk:ApfCD mouse , 2000, FEBS letters.

[61]  O. Fiehn,et al.  Metabolite profiling for plant functional genomics , 2000, Nature Biotechnology.

[62]  J. Lindon,et al.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[63]  E Holmes,et al.  High‐resolution magic angle spinning 1H NMR spectroscopic studies on intact rat renal cortex and medulla , 1999, Magnetic resonance in medicine.

[64]  S. W. Davies,et al.  Transgenic models of Huntington's disease. , 1997, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[65]  J. Lindon,et al.  Uroscopy in the 21st century: high-field NMR spectroscopy. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[66]  S. W. Davies,et al.  Transgenic models of Huntington's disease. Hum Mol Genet 6:1633-1637 , 1997 .

[67]  I. Wilson,et al.  Nuclear magnetic resonance and high-performance liquid chromatography-nuclear magnetic resonance studies on the toxicity and metabolism of ifosfamide. , 1996, Therapeutic drug monitoring.

[68]  C. Beddell,et al.  Automatic data reduction and pattern recognition methods for analysis of 1H nuclear magnetic resonance spectra of human urine from normal and pathological states. , 1994, Analytical biochemistry.

[69]  J. Kilburn,et al.  Rapid identification of mycolic acid patterns of mycobacteria by high-performance liquid chromatography using pattern recognition software and a Mycobacterium library , 1994, Journal of clinical microbiology.

[70]  A. Falek,et al.  Guidelines for the molecular genetics predictive test in Huntington's disease , 1994 .

[71]  B. Rosen,et al.  Evidence for irnnairment of energy metabofism in vivo in Huntington's disease using localized 1H NMR spectroscopy , 1993, Neurology.

[72]  J. M. Carr,et al.  Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma. , 1986, The New England journal of medicine.

[73]  P J Sadler,et al.  Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. , 1984, Clinical chemistry.

[74]  A. Buck,et al.  Epidemiology of poly-parasitism. I. Occurrence, frequency and distribution of multiple infections in rural communities in Chad, Peru, Afghanistan, and Zaire. , 1978, Tropenmedizin und Parasitologie.

[75]  R. Guthrie,et al.  A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS. , 1963, Pediatrics.